Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: Prandial premixed (Lispro/ILPS) vs basal/bolus (Glargine/Lispro) therapy

被引：0

作者：

Ahmann, A. J.

Rosenstock, J.

Colon, G.

Scism-Bacon, J.

Jiang, H. H.

Martin, S.

机构：

[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[2] Dallas Diabet & Endocrine Ctr, Dallas, TX USA

[3] San Juan Hlth Care, San Juan, PR USA

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

DIABETOLOGIA | 2007年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

0991

引用

页码：S410 / S410

页数：1

共 50 条

[1] Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents - Prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy
Rosenstock, Julio
Scism-Bacon, Jamie
Ahmann, Andrew J.
Jiang, Honghua
Colon, Gildred
Martin, Sherry
[J]. DIABETES CARE, 2008, 31 (01) : 20 - 25
[2] Intensive insulin therapy in type 2 diabetes (T2D) patients previously treated with glargine plus oral agents: Prandial NPL/lispro mixtures vs glargine/lispro basal/bolus
Rosenstock, Julio
Ahmann, Andrew J.
Colon, Gildred
Scism-Bacon, Jamie L.
Jiang, Honghua H.
Martin, Sherry
[J]. DIABETES, 2007, 56 : A51 - A51
[3] A comparison of prandial premixed (ILPS/lispro) vs basal bolus (glargine/lispro) insulin therapy in obese patients with type 2 diabetes (T2D)
Ahmann, Andrew
Jiang, Honghua
Martin, Sherry A.
[J]. DIABETES, 2008, 57 : A564 - A564
[4] Hypoglycemia rates with titration of prandial premixed (ILPS/lispro) or basal bolus (glargine/lispro) insulin therapy in patients with type 2 diabetes (T2D)
Ahmann, Andrew
Jiang, Honghua
Martin, Sherry A.
[J]. DIABETES, 2008, 57 : A146 - A146
[5] Basal insulin glargine vs prandial insulin lispro in type 2 diabetes
Arnolds, Sabine
Rave, Klaus
[J]. LANCET, 2008, 372 (9636): : 370 - 371
[6] Basal insulin glargine vs prandial insulin lispro in type 2 diabetes -: Reply
Linn, Thomas
Landgraf, W.
Bretzel, Reinhard G.
[J]. LANCET, 2008, 372 (9636): : 372 - 372
[7] Efficacy and safety of prandial premixed (ILPS/lispo) vs basal bolus (glargine/lispro) insulin therapy in Hispanic and African American patients with type 2 diabetes (T2D)
Colon, Gildred
Jiang, Honghua
Martin, Sherry A.
[J]. DIABETES, 2008, 57 : A143 - A144
[8] Prandial insulin substitution with insulin lispro or insulin lispro, mid mixture vs. basal therapy with insulin glargine:: A randomized controlled trial in patients with type 2 diabetes beginning insulin therapy
Kazda, C
Hülstrunk, H
Helsberg, K
Langer, F
Forst, T
Hanefeld, M
[J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (03) : 145 - 152
[9] Equivalence of basal insulin glargine vs prandial insulin lispro for glucose control in type 2 diabetes patients on oral agents - Results of the APOLLO study
Bretzel, Reinhard G.
Linn, Thomas
[J]. DIABETES, 2006, 55 : A76 - A76
[10] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Riccardo Candido
Kathleen Wyne
Ester Romoli
[J]. Diabetes Therapy, 2018, 9 : 927 - 949

← 1 2 3 4 5 →